Search
for
Sort by
Research 61–90 of 305
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men
- Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Misdiagnosis of eosinophilic cystitis: A case report and literature review
- Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna
- Editorial Comment
- 1304 Assessing Post Operative Continuation of LUTs Medication Following TURP and BiPolep
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- A pharmacovigilance study of drug‐reduced male semen quality based on the Food and Drug Administration adverse event reporting system database
- Maculopapular Drug Eruption Caused by Finasteride: A Case Report
- Особливості перебігу симптомів нижніх сечових шляхів у чоловіків із доброякісною гіперплазією передміхурової залози та COVID-19
- Serenoa repens (saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- MP27-18 STATEWIDE GEOGRAPHIC PRICE VARIATION OF GENERIC BPH MEDICATIONS
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- MP86-01 VARIABILITY OF RETAIL PRICING OF GENERIC UROLOGIC MEDICATIONS IN A MAJOR US METROPOLITAN AREA
- A study of risk factors and predictive factors in intraoperative floppy iris syndrome during phacoemulsification
- 332 Recognizing and Treating Undiagnosed Erectile Dysfunction (ED) in Patients Presenting With Lower Urinary Tract Symptoms (LUTS)
- The study of preventing floppy iris syndrome during age-related cataract surgery
- Experience of using of Sonirid Duo in treatment of patients with BPH
- Diagnosis and treatment of prostatitis after TURP